Organization
Palatin Technologies Inc.
Topic
All Topics
People
Find news about people
Alumni
Find news on alumni of any org
Industries
Find news on a particular market
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed
Palatin Technologies Inc.
... Palatin Technologies, Inc. (NYSE MKT: PTN; "Palatin") announced today that it has entered into a ...
... Palatin Technologies, Inc. (NYSE MKT: PTN), a biopharmaceutical company developing targeted, receptor-specific peptide therapeutics for ...
... Palatin Technologies, Inc. (NYSE MKT: PTN) will announce its first quarter, fiscal year 2018 operating ...
... Palatin Technologies, Inc. (NYSE MKT: PTN), a biopharmaceutical company developing targeted, receptor-specific peptide therapeutics for ...
... Palatin Technologies, Inc. (NYSE MKT: PTN) will announce its fourth quarter and fiscal year end ...
... If you want a Stock Review on AMAG, IDXX, PTN, or BPTH then come over tohttp://dailystocktracker.com/register/and sign up for your free customized ...
... Palatin Technologies, Inc. (NYSE MKT: PTN), a biopharmaceutical company developing targeted, receptor-specific peptide therapeutics for ...
... Palatin Technologies, Inc. (NYSE MKT: PTN; "Palatin") announced today that it has entered into a ...
... has issued research reports on Valeant Pharmaceuticals International Inc. (NYSE: VRX), Palatin Technologies Inc. (NYSEMKT: PTN), AMAG Pharmaceuticals Inc. (NASDAQ: AMAG), and IDEXX Laboratories Inc. ...
... Plc , NAL Pharmaceuticals Ltd , Nanoform Cardiovascular Therapeutics Ltd , Palatin Technologies Inc , Pharmicell Co Ltd , SK Chemicals Co Ltd , Suda ...
... DailyStockTracker.com has initiated research reports on the following Healthcare stocks: Palatin Technologies Inc. (NYSE MKT: PTN), Centene Corp. (NYSE: CNC), Anthem Inc. (NYSE: ANTM), and ...
... as Executive Vice President, Secretary, Treasurer and Chief Financial Officer of Palatin Technologies, Inc., a publicly-held biopharmaceutical company developing targeted, receptor-specific peptide therapeutics for the ...
... Palatin Technologies, Inc. (NYSE MKT: PTN), a biopharmaceutical company developing targeted, receptor-specific peptide therapeutics for ...
... Palatin Technologies, Inc. (NYSE MKT: PTN) will announce its third quarter, fiscal year 2017 operating ...
... was primarily due to a one-time payment of $60 million to Palatin Technologies, Inc. related to the bremelanotide licensing transaction. Non-GAAP adjusted EBITDA increased approximately ...
... was primarily due to a one-time payment of $60 million to Palatin Technologies, Inc. related to the bremelanotide licensing transaction. Non-GAAP adjusted EBITDA increased approximately ...
... looks at the performance of these four Diagnostic Substances stocks: Palatin Technologies Inc. (NYSE MKT: PTN), AMAG Pharmaceuticals Inc. (NASDAQ: AMAG), IDEXX Laboratories Inc. (NASDAQ: ...
... Biosciences Inc, Novartis AG, Nuo Therapeutics Inc, Nyken BV, Orion Oyj, Palatin Technologies Inc, PharmaIN Corp, PhaseBio Pharmaceuticals Inc, Quantum Genomics SA, Recardio GmbH, RedHill ...
... Palatin Technologies, Inc. (NYSE MKT: PTN), a biopharmaceutical company developing targeted, receptor-specific peptide therapeutics for ...
... reviews these four Healthcare stocks: Delcath Systems Inc. (NASDAQ: DCTH), Palatin Technologies Inc. (NYSE MKT: PTN), AMAG Pharmaceuticals Inc. (NASDAQ: AMAG), and IDEXX Laboratories Inc. ...
... Palatin Technologies, Inc. (NYSE MKT: PTN) announced today that it will be presenting at the ...
... 2017 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (Nasdaq:AMAG) together with Palatin Technologies, Inc. (NYSE MKT:PTN) announced that additional results from the Phase 3 RECONNECT Studies ...
Want to see the full history of news or view news on a particular date? Upgrade to RelSci Professional now!
Start My Free Trial ➤